17 results
10-K
2023 FY
EX-4.4
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
% of the voting power of all of our issued and outstanding shares, such acquired shares will not have any voting rights unless such rights are restored … shareholder approval. Our board of directors will have discretion to determine the rights, preferences, privileges and restrictions, including voting
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
, such acquired shares will not have any voting rights unless such rights are restored by the holders of a majority of the votes of each class or series
8-K
EX-10.2
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
applicable transfer taxes.
5. No Rights as Stockholder until Exercise. This Warrant does not entitle the Holder to any voting rights or other rights
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
power of all of our issued and outstanding shares, such acquired shares will not have any voting rights unless such rights are restored by the holders … of directors will have discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights
424B1
lmwhxc
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-3.1
9wvjpjj6z8mgw4i7
29 Jun 23
IPO registration
4:39pm
S-1
EX-4.3
rhjry30
29 Jun 23
IPO registration
4:39pm
S-1
n3tzoe l325y8
29 Jun 23
IPO registration
4:39pm
DRS/A
qkuw382 6b
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-4.3
81b2x
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
52tk5fq
2 May 23
Draft registration statement (amended)
12:00am
DRS
xe2h4j i637o
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next